Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Patrys Limited (AU:PAB)
ASX:PAB
PAB Stock Chart & Stats
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.01
Previous CloseN/A
Volume5.08M
Average Volume (3M)2.15M
Market Cap
€6.17M
Enterprise ValueAU$12.15M
Total Cash (Recent Filing)1.91M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.30
Next Earnings
Feb 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding2,057,447,300
10 Day Avg. Volume1,582,640
30 Day Avg. Volume2,150,056
Standard Deviation0.23
R-Squared0.05
Alpha-0.00769
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1924.98
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Patrys Limited News
PremiumCompany Announcements
Patrys Limited Refocuses on PAT-DX3 Amidst Testing Challenges
PremiumCompany Announcements
Patrys Limited Director Updates Stock Options Holdings
PremiumCompany Announcements
Patrys Limited Strengthened by R&D Tax Incentive
PremiumCompany Announcements
Patrys Limited AGM Resolutions Successfully PassedPremiumCompany Announcements
Patrys Limited Shifts Focus to Promising PAT-DX3 Development
PremiumCompany Announcements
Patrys Limited Shifts Focus to Promising Antibody PAT-DX3
PremiumCompany Announcements
Patrys Limited Announces Virtual AGM for 2024
PremiumCompany Announcements
Patrys Limited Refocuses on Promising PAT-DX3 Antibody---
PAB FAQ
What was Patrys Limited’s price range in the past 12 months?
Patrys Limited lowest share price was <AU$0.01 and its highest was AU$0.01 in the past 12 months.
What is Patrys Limited’s market cap?
Patrys Limited’s market cap is €6.17M.
When is Patrys Limited’s upcoming earnings report date?
Patrys Limited’s upcoming earnings report date is Feb 21, 2025 which is in 14 days.
How were Patrys Limited’s earnings last quarter?
Patrys Limited released its earnings results on Aug 23, 2024. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.
Is Patrys Limited overvalued?
According to Wall Street analysts Patrys Limited’s price is currently Overvalued.
Does Patrys Limited pay dividends?
Patrys Limited does not currently pay dividends.
What is Patrys Limited’s EPS estimate?
Patrys Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Patrys Limited have?
Patrys Limited has 2,057,447,300 shares outstanding.
What happened to Patrys Limited’s price movement after its last earnings report?
Patrys Limited reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Patrys Limited?
Currently, no hedge funds are holding shares in AU:PAB
---
Patrys Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
-67.69%
Trailing 12-Months
Asset Growth
-43.51%
Trailing 12-Months
Company Description
Patrys Limited
Patrys Ltd focuses on the development of natural human antibody-based therapies for the treatment of cancer. The company's product includes Deoxymab 3E10, PAT-SC1, PAT-DX1 and PAT-DX1-NP, and PAT-LM1. Its lead technology is Deoxymab 3E10, a DNA damage repair (DDR) antibody which penetrates live cell nuclei and inhibits key mechanisms of DNA repair in target cancer cells.
---
Biotron Limited
―
Opthea Limited
―
Immutep Ltd
―
PYC Therapeutics Limited
―
Race Oncology Ltd.
―
---